Description
THIS REPORT:
Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics
Offers a global analysis, with emphasis on U.S. data, and a fiv...(more)
Description
Key Trends in Drug-Diagnostic Co-Development
Identifying collaborative opportunities and navigating regulatory challenges
Report Overview
The development of genomics-based ...(more)
Description
Introduction
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters
or mega-blockbusters. This market success is due not only to ...(more)
Description
Introduction
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new te...(more)
Description
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? ...(more)
Description
Report description
Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry&r...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
REPORT HIGHTLIGHTS
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. The market is analyzed by Location-wise (Clinical Laboratory Testing, and Point-of-Care Testing) and by Assay type...(more)
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
Introduction
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer ...(more)
Description
Monoclonal antibodies in cancer therapy - significant commercial opportunities with developing technologies and innovative products - our new report explains prospects
Monoclonal antibody-bas...(more)
Description
The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)
Description
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics woul...(more)
Description
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease-...(more)
Description
India Medical Equipment Markets: Investment Opportunities, Analysis and Forecasts in Medical Devices to 2015
Summary
This report is an essential source for in-depth information an...(more)
Description
Despite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century. Indeed,...(more)
Description
Switzerland’s CHF5.9bn (US$5.4bn) drug market has so far avoided the worst effects of the globalfinancial crisis, growing by around 4% in Swiss francs in 2008, However, the next five years are l...(more)
Description
Details the disease states that lead to memory & cognition impairment
Provides forecasts and detail relative to the products available to treat this condition.
Provides definition and ma...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
